Biotechnology News

July 22, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.52 per Baxter common share. The dividend is payable on October 1, 2014 to shareholders of record as of...

July 22, 2014

BOSTON--(BUSINESS WIRE)--HighRes Biosolutions was selected by the Scottish Universities Life Sciences Alliance (SULSA) to provide multiple automated robotic platforms to support the UK National Phenotypic Screening Centre.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets 3rd Annual Biotech Corporate Access Day on July 29, 2014. There will be no formal presentations or webcasting at...

July 22, 2014

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics announced today that findings from a clinical study supporting performance of the ChemoFx® drug response marker as a predictive marker have been released by British Journal of Cancer, an elite...

July 22, 2014

SAN DIEGO--(BUSINESS WIRE)--The NHLBI, a division of the NIH, has selected Cytori technology for a clinical trial aimed at further improving outcomes in patients receiving LVAD procedures.

July 22, 2014

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Vivione Biosciences is proud to announce that it has received an Association of Analytical Communities certification for its E. coli O157 and Non O157 STEC diagnostic tests for the RAPID-B platform.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the...

July 22, 2014

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics announced today that it will host a live webcast of its third quarter 2014 conference call on July 31 at 5 p.m. ET and will issue an earnings news release after market closes that afternoon.

July 22, 2014

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will...

July 22, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announced CE Mark approval and first use of the FlexAbility™ Ablation Catheter, a novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea presented data from the Phase 1/2a study of GEN-003 against HSV-2 demonstrating significant, durable T cell responses in vaccinated subjects.

July 22, 2014

DOHA, Qatar & SAN DIEGO--(BUSINESS WIRE)--Sidra Medical and Research Center will house a first-of-its-kind facility, the High-Throughput Genomics Center, to undertake population studies and genetic sequencing for the MENA region. The facility...

July 22, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that the date for its second quarter 2014 financial results press release will be Tuesday, August 5, 2014, prior to the opening of the U.S. stock markets. Similar to the...

July 22, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences today announced its second-quarter 2014 financial results.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc., a biotechnology company focused on the development of therapeutic microbes, today announced the company raised $29.4 million in a Series A financing led by Atlas Venture and NEA.

July 22, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Receives FDA Clearance for ARROW-Clark VectorFlow Chronic Hemodialysis Catheter

July 22, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the first patient has been dosed in a double-blind, multiple-dose, phase 3 study to evaluate the efficacy and safety of QuickShot® Testosterone (QS T)...

July 22, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to the newly created position of group president, Covidien,...

July 22, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides celebrated grand opening of its new state of the art cGMP pilot manufacturing and R&D facility in Shelton, CT, with Chief Guest Congressman Jim Himes presiding, on July 21.

July 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics (NASDAQ: SAGE) announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation to the SAGE-547 development program to treat status epilepticus.

July 22, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO launches a new global phase III trial in Polycythemia vera in collaboration with AOP Orphan.

July 22, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

July 22, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License...

July 22, 2014

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first half of 2014 with significant gains. Consolidated order intake grew 8.9% in...

July 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Assay Depot Inc., the pharmaceutical industry’s leading marketplace for scientific services, today announced a partnership to build an academic Research Exchange for use by scientists at ten leading research hospitals...

July 21, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its second quarter 2014 financial results on Thursday, August 7, 2014, after the close of the U.S. financial markets. Clovis’ senior management will host a...

July 21, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with AML and High-Risk MDS

July 21, 2014

DUBLIN & LEXINGTON, Mass.--(BUSINESS WIRE)--Jazz Pharmaceuticals and Concert Pharmaceuticals initiated a first-in-human Phase 1 study with JZP-386.

July 21, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--World leaders and celebrities came to St. Paul, Minn. to support and celebrate the Starkey Hearing Foundation’s 14th annual So the World May Hear Awards Gala. The event raised more than $8.7 million.

July 21, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the launch of Sitavig® (acyclovir...

July 21, 2014

ANTONY, France--(BUSINESS WIRE)--STALLERGENES (Paris:GENP), a global healthcare company specialized in the diagnosis and treatment of allergies through allergen immunotherapy-based solutions, announced today the acquisition of the entire share...

July 21, 2014

BAGNEUX, France--(BUSINESS WIRE)--Reaching significant milestones within the framework of the partnership with Quest Diagnostics.

July 21, 2014

ROSWELL, Ga.--(BUSINESS WIRE)--CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix® ECM® for Vascular Repair. The CorMatrix ECM for Vascular Repair is intended...

July 21, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Biolase to Raise $12 Million from Institutional and Individual Investors in Private Placement

July 21, 2014

BALTIMORE--(BUSINESS WIRE)--Cerecor closes on first tranche of $32M Series B financing for its lead candidate, CERC-301, as an adjunctive antidepressant with rapid onset of action, and COMT inhibitor platform.

July 21, 2014

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human efficacy related to muscle cramping in healthy...

July 21, 2014

DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) is honored to announce the Amgen Foundation’s grant of $25,000 to the Colorado BioScience Institute (CBSI) in support of the RET program.

July 21, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--ABL, Inc. announces the acquisition of a majority interest in Platine Pharma Services. The acquisition will expand ABL's capabilities in immunological assay services and provide a presence in Europe.

July 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics announced that the underwriters of its initial public offering (IPO) exercised in full their option to purchase from SAGE 750,000 additional shares of its common stock.

July 21, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its pancreatic cancer combination...

July 21, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended June 30, 2014. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share,...

July 21, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Proteon Therapeutics initiates Phase 3 clinical study of its lead product, PRT-201, in patients with chronic kidney disease undergoing surgical placement of an arteriovenous fistula for hemodialysis

July 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea commences a phase 2 dose optimization trial for GEN-003, the company's immunotherapy against herpes simplex-type 2.

July 21, 2014

READING, England--(BUSINESS WIRE)--Quintiles has been named Britain's Healthiest Large Workplace

July 21, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the successful completion of the acquisition of Labrys. The acquisition of Labrys brings to Teva LBR-101, a fully humanized monoclonal antibody that binds...

July 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced the multicenter initiation of the company’s global Phase I/II clinical trial of RXDX-101, its proprietary oral tyrosine...